HUP9801572A2 - Chlamydia-vakcinák - Google Patents

Chlamydia-vakcinák

Info

Publication number
HUP9801572A2
HUP9801572A2 HU9801572A HUP9801572A HUP9801572A2 HU P9801572 A2 HUP9801572 A2 HU P9801572A2 HU 9801572 A HU9801572 A HU 9801572A HU P9801572 A HUP9801572 A HU P9801572A HU P9801572 A2 HUP9801572 A2 HU P9801572A2
Authority
HU
Hungary
Prior art keywords
chlamydia vaccines
vaccines
chlamydia
chlamydial
immunostimulants
Prior art date
Application number
HU9801572A
Other languages
English (en)
Inventor
Jean-Franqois Maiisonneuve
Jean-Paul Prieels
Moncef Mohamed Slaoui
Vincent Verlant
Original Assignee
Smithkline Beecham Biologicals S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Biologicals S.A. filed Critical Smithkline Beecham Biologicals S.A.
Publication of HUP9801572A2 publication Critical patent/HUP9801572A2/hu
Publication of HUP9801572A3 publication Critical patent/HUP9801572A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/118—Chlamydiaceae, e.g. Chlamydia trachomatis or Chlamydia psittaci
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/295—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Chlamydiales (O)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Reproductive Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gynecology & Obstetrics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)

Abstract

A találmány tárgyát képezik chlamydia-fertőzés megelőzésére szőlgálóúj vakcinák, amelyek chlamydia külső membrán prőteint és két 3D/MPL ésQS2 elnevezésű imműnstiműlánst tartalmaznak. ŕ
HU9801572A 1995-04-03 1996-04-01 Chlamydia vaccines HUP9801572A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9506863.1A GB9506863D0 (en) 1995-04-03 1995-04-03 Vaccines

Publications (2)

Publication Number Publication Date
HUP9801572A2 true HUP9801572A2 (hu) 1998-10-28
HUP9801572A3 HUP9801572A3 (en) 1999-04-28

Family

ID=10772426

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9801572A HUP9801572A3 (en) 1995-04-03 1996-04-01 Chlamydia vaccines

Country Status (23)

Country Link
EP (1) EP0820304B1 (hu)
JP (2) JPH11503142A (hu)
KR (1) KR19980703666A (hu)
CN (1) CN1185740A (hu)
AT (1) ATE193974T1 (hu)
AU (1) AU700548B2 (hu)
BR (1) BR9604853A (hu)
CA (1) CA2215520C (hu)
CZ (1) CZ313497A3 (hu)
DE (1) DE69608959T2 (hu)
DK (1) DK0820304T3 (hu)
ES (1) ES2149466T3 (hu)
GB (1) GB9506863D0 (hu)
GR (1) GR3033764T3 (hu)
HK (1) HK1008495A1 (hu)
HU (1) HUP9801572A3 (hu)
NO (1) NO974561L (hu)
NZ (1) NZ306443A (hu)
PL (1) PL322620A1 (hu)
PT (1) PT820304E (hu)
TR (1) TR199701113T1 (hu)
WO (1) WO1996031236A1 (hu)
ZA (1) ZA962616B (hu)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9626864D0 (en) * 1996-12-24 1997-02-12 Smithkline Beecham Biolog Vaccine
US7459524B1 (en) 1997-10-02 2008-12-02 Emergent Product Development Gaithersburg Inc. Chlamydia protein, sequence and uses thereof
US6306404B1 (en) 1998-07-14 2001-10-23 American Cyanamid Company Adjuvant and vaccine compositions containing monophosphoryl lipid A
GB9819898D0 (en) * 1998-09-11 1998-11-04 Smithkline Beecham Plc New vaccine and method of use
US20020061848A1 (en) 2000-07-20 2002-05-23 Ajay Bhatia Compounds and methods for treatment and diagnosis of chlamydial infection
US6635261B2 (en) 1999-07-13 2003-10-21 Wyeth Holdings Corporation Adjuvant and vaccine compositions containing monophosphoryl lipid A
US20010048927A1 (en) 2000-02-01 2001-12-06 Richard Stephens Porin B (PorB) as a therapeutic target for prevention and treatment of infection by chlamydia
US7105171B2 (en) 2002-03-07 2006-09-12 The Regents Of The University Of California Porin B (PorB) as a therapeutic target for prevention and treatment of infection by Chlamydia
US8541007B2 (en) 2005-03-31 2013-09-24 Glaxosmithkline Biologicals S.A. Vaccines against chlamydial infection
MX2007012108A (es) * 2005-03-31 2007-12-05 Glaxosmithkline Biolog Sa Vacunas contra infeccion por chlamydia.
CN103068837B (zh) 2010-05-28 2015-06-24 斯匹遐生物技术公司 嵌合momp抗原、方法和使用
CN113940994B (zh) * 2021-11-09 2023-09-15 南华大学 壳聚糖-Pickering乳液白细胞介素12佐剂体系的制备方法及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL9000207A (hu) * 1990-01-29 1991-08-16 Duphar Int Res
WO1992010203A1 (en) * 1990-12-10 1992-06-25 Alving Carl R A vaccine against cholesterol to prevent hypercholesterolemia and atherosclerosis
CH682455A5 (fr) * 1991-07-25 1993-09-30 Serge Liotet Composition vaccinale.
JPH05339169A (ja) * 1992-03-03 1993-12-21 Dai Ichi Seiyaku Co Ltd 経口ワクチン
PT761231E (pt) * 1992-06-25 2000-06-30 Smithkline Beecham Biolog Composicao de vacina contendo adjuvantes

Also Published As

Publication number Publication date
ZA962616B (en) 1996-11-27
DE69608959D1 (de) 2000-07-27
HK1008495A1 (en) 1999-05-14
BR9604853A (pt) 1998-06-16
CA2215520C (en) 2008-01-22
JP2007308508A (ja) 2007-11-29
GB9506863D0 (en) 1995-05-24
EP0820304A1 (en) 1998-01-28
GR3033764T3 (en) 2000-10-31
CA2215520A1 (en) 1996-10-10
CN1185740A (zh) 1998-06-24
DK0820304T3 (da) 2000-08-28
MX9707638A (es) 1998-06-28
PL322620A1 (en) 1998-02-02
ES2149466T3 (es) 2000-11-01
PT820304E (pt) 2000-11-30
NZ306443A (en) 1999-02-25
CZ313497A3 (cs) 1998-03-18
ATE193974T1 (de) 2000-07-15
AU5499996A (en) 1996-10-23
NO974561D0 (no) 1997-10-02
TR199701113T1 (xx) 1998-03-21
NO974561L (no) 1997-11-26
EP0820304B1 (en) 2000-06-21
WO1996031236A1 (en) 1996-10-10
AU700548B2 (en) 1999-01-07
JPH11503142A (ja) 1999-03-23
KR19980703666A (ko) 1998-12-05
HUP9801572A3 (en) 1999-04-28
DE69608959T2 (de) 2000-11-16

Similar Documents

Publication Publication Date Title
PT865297E (pt) Composicoes de vacinas para administracao intranasal compreendendo quitosano e suas utilizacoes
BR9610262B1 (pt) Compostos e métodos para a imunoterapia e diagnose de tuberculose.
HUP9802819A2 (hu) Hősokkfehérje-alapú oltóanyagok és immunterápiák
TR200001835T2 (tr) Aşı.
ITFI920052A0 (it) Proteina estratta da ceppi citotossici di helicobacter pylori, gene che la esprime, uso della proteina come vaccino o diagnostico.
PT770397E (pt) Vacina de combinacao contra o virus da doenca de newcastle
HUP9801572A2 (hu) Chlamydia-vakcinák
HUP0302636A2 (hu) Hasított burkolt víruskészítmény
NO912825D0 (no) Fremgangsmaate for fremstilling av cokonjugate vaksiner omfattende immunogenisk protein, hiv-beslektede peptider og anioniske grupper.
PT854924E (pt) Antigenios de leishmania para uso na terapia e diagnostico da leishmaniose
ES2137310T3 (es) Vacuna contra una infeccion por streptococcus suis.
HUP9802349A2 (hu) Allergén - XCD32 fúziós fehérjék és eljárás allergiaellenes gyógyszerkészítmény előállítására
NO981019L (no) Deodoriserende preparater inneholdende kationiske biopolymerer, aluminiumklorhydrat og esteraseinhibitorer
ATE334697T1 (de) Boviner atmungs- und darmcoronavirus als impfstoff
DK0493575T3 (da) Vaccine af reassortant rotavirus
ES2176363T3 (es) Peptidos de la proteina gag del vih, su preparacion y su uso.
AU1825895A (en) Retroviral vaccines, vaccination and immune-therapy for retroviral infections
NZ316110A (en) vaccine containing an antigen from H. Influenzae and an antigen from influenza virus
RU97104467A (ru) Штамм chlamydia psittaci, используемый для изготовления инактивированной вакцины против хламидиоза кошек и пушных зверей